1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2021 - Europe

Healthcare Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Pharma Intelligence
1-30 of about 100 reports

Point of Care Diagnostics

  • $ 4750
  • June 2021
  • 121 pages

Overview Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. ...

  • World
  • Spain
  • In Vitro Diagnostics
  • Point Of Care Testing
  • Industry analysis

Arthroscopy Products and Sports Medicine Fixation Implants (2021)

  • $ 4750
  • March 2021
  • 116 pages

Overview Global sales of arthroscopy products and sports medicine fixation implants are expected to increase at a 1.9% CAGR during the 2020-25 forecast period, reaching more than $6.3bn in 2025. This ...

  • Europe
  • World
  • Spinal Implant
  • Industry analysis

Company Analysis: Shionogi

  • $ 3000
  • January 2021
  • 40 pages

PharmaVitae explores Shionogi’s prescription pharmaceutical performance and outlook through to 2029. Snapshot Overview – PharmaVitae forecasts Shionogi’s revenue to remain flat through 2029, ...

  • Japan
  • United States
  • Prescription Drug
  • Influenza
  • Company research
  • Company

Company Analysis: Astellas

  • $ 3000
  • January 2021
  • 45 pages

PharmaVitae explores Astellas’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Astellas is forecast to grow revenue until 2026, at which point flagship ...

  • United States
  • Europe
  • Prostate Cancer
  • Company research
  • Company

Company Analysis: United Therapeutics

  • $ 3000
  • January 2021
  • 34 pages

PharmaVitae explores United Therapeutics’ prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – United Therapeutics’ prescription pharmaceutical business is ...

  • World
  • Europe
  • Pharmaceutical
  • Prescription Drug
  • Company research
  • Company

Company Analysis: Gilead

  • $ 3000
  • January 2021
  • 67 pages

PharmaVitae explores Gilead’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Gilead’s sales will remain broadly stable over the medium term due to its ...

  • United States
  • Europe
  • Prescription Drug
  • Autoimmune Disease
  • Company research
  • Company

Company Analysis: UCB

  • $ 3000
  • January 2021
  • 38 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Extremity Replacement Implants

  • $ 4750
  • December 2020
  • 65 pages

Overview This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided ...

  • World
  • Europe
  • General Medicine And Specialty Medicine
  • Industry analysis

Wound Care: Advanced Dressings and Closure Products

  • $ 4750
  • November 2020
  • 122 pages

OVERVIEW In 2019, sales of advanced wound care products in the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Rest of World markets totaled nearly $8.2bn; of ...

  • Europe
  • World
  • Wound Care
  • Wound Closure
  • Industry analysis

Johnson & Johnson Company Analysis, Pharma Intelligence

  • $ 3000
  • July 2020
  • 62 pages

PharmaVitae explores Johnson and Johnson’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Johnson and Johnson’s growth will be driven by its pharmaceuticals ...

  • United States
  • Europe
  • Pharmaceutical
  • Leukemia
  • Company research
  • Company

UCB Company Analysis

  • $ 3000
  • July 2020
  • 43 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI products ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Biogen

  • $ 3000
  • July 2020
  • 41 pages

PharmaVitae explores Biogen’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Biogen’s prescription pharmaceutical business will see stable performance ...

  • United States
  • European Union
  • Prescription Drug
  • Neurological Disorder
  • Industry analysis

Alexion

  • $ 3000
  • July 2020
  • 43 pages

PharmaVitae explores Alexion’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Alexion’s rare diseases portfolio maintains its solid growth and attractive ...

  • Europe
  • Japan
  • Infectious Disease
  • Neurology
  • Industry analysis

2019 Biomedtracker / Datamonitor Healthcare Post-ESMO Report

  • $ 4750
  • October 2019
  • 117 pages

The Annual European Society for Medical Oncology (ESMO) 2019 Congress was held in Barcelona, Spain from September 27 to October 1, 2019. Conference highlights included new data from PARP inhibitors in ...

  • Spain
  • Catalonia
  • Breast Cancer
  • Targeted Therapy
  • Industry analysis

Drug Delivery: Inhalation Devices

  • $ 4750
  • October 2019
  • 47 pages

Overview In 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

  • World
  • Spain
  • Asthma
  • Drug Delivery
  • Industry analysis
  • Asthma Prevalence

Vaccines Market Access in Emerging Markets

  • $ 3000
  • August 2019
  • 76 pages

Overview Emerging markets account for approximately 18% of the global vaccines market, which is valued at more than $24bn. However, there are indications that this is an underestimate, and some observers ...

  • World
  • Europe
  • Healthcare
  • Medical Device
  • Industry analysis
  • Medical Technology Density

General and Pelvic Endoscopic Surgery

  • $ 4750
  • May 2019
  • 230 pages

This Meddevicetracker report provides an analysis of the market for general and pelvic endoscopic surgery products in the US, five major EU markets, Japan, and the rest of the world. Market segments covered ...

  • World
  • Japan
  • Endoscope
  • Industry analysis

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

  • $ 3000
  • November 2018
  • 80 pages

Payers are concerned about the budget impact of immunotherapies As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, interviewed payers express concern surrounding ...

  • Europe
  • Hepatitis
  • Immunotherapy
  • Industry analysis

ISPOR Europe 2018 Whitepaper

  • $ 2995
  • November 2018
  • 11 pages

Datamonitor Healthcare attended the ISPOR 21st Annual European Congress held in Barcelona on 10–14 November. Here, we present some of the hot topics discussed at the event, including: The Trump adm ...

  • United States
  • Europe
  • Pharmaceutical
  • Therapy
  • Industry analysis
  • Health Expenditure
  • Medical Technology Density

Market Access Trends in Europe

  • $ 3000
  • November 2018
  • 125 pages

Overview Europe’s payers face a thorny problem. As regulators strive to expedite the approval of innovative medicines, they are being asked to fund a steady stream of new drugs targeting serious, intractable, ...

  • World
  • Europe
  • Pharmaceutical
  • Healthcare
  • Industry analysis
  • Drug Approval
  • Medical Technology Density

Market Spotlight: Systemic Lupus Erythematosus (SLE)

  • $ 1318
  • May 2021
  • 40 pages

This Market Spotlight report covers the Systemic Lupus Erythematosus (SLE) market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory ...

  • World
  • Europe
  • Clinical Trial
  • Musculoskeletal Disorder
  • Industry analysis
  • Drug Approval

Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL), Pharma Intelligence

  • $ 1318
  • May 2021
  • 45 pages

This Market Spotlight report covers the Cutaneous T-Cell Lymphoma (CTCL) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, ...

  • World
  • Europe
  • Clinical Trial
  • Lymphoma
  • Industry analysis

Market Spotlight: Eating Disorders, Pharma Intelligence

  • $ 1318
  • April 2021
  • 32 pages

This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, a 10-year disease ...

  • World
  • Europe
  • Eating Disorder
  • Industry analysis
  • Drug Approval

Market Spotlight: Uterine Cancer, Pharma Intelligence

  • $ 1318
  • April 2021
  • 42 pages

This Market Spotlight report covers the Uterine Cancer market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • World
  • Europe
  • Cancer
  • Clinical Trial
  • Industry analysis
  • Drug Approval

Market Spotlight: Fibromyalgia

  • $ 1318
  • March 2021
  • 37 pages

This Market Spotlight report covers the Fibromyalgia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability ...

  • World
  • Europe
  • Chronic Pain
  • Clinical Trial
  • Industry analysis
  • Drug Approval

Market Spotlight: Basal Cell Carcinoma, Pharma Intelligence

  • $ 1318
  • March 2021
  • 35 pages

This Market Spotlight report covers the Basal Cell Carcinoma market, comprising key marketed and pipeline drugs, epidemiology, recent events and analyst opinion, clinical trials, upcoming and regulatory ...

  • World
  • Europe
  • Cancer
  • Industry analysis
  • Drug Approval

Market Spotlight: Zika virus, Pharma Intelligence

  • $ 1318
  • February 2021
  • 24 pages

This Market Spotlight report covers the Zika virus market, comprising key pipeline therapies, clinical trials, probability of success, epidemiology, and licensing and acquisition deals. Key Takeaways The ...

  • World
  • South America
  • Infectious Disease
  • Industry analysis

Market Spotlight: Hidradenitis Suppurativa, Pharma Intelligence

  • $ 1318
  • February 2021
  • 33 pages

This Market Spotlight report covers the Hidradenitis Suppurativa market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of ...

  • World
  • Europe
  • Clinical Trial
  • Autoimmune Disease
  • Industry analysis
  • Drug Approval

Market Spotlight: Hepatitis B

  • $ 1318
  • February 2021
  • 55 pages

This Market Spotlight report covers the Hepatitis B market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events, probability of success, ...

  • World
  • Europe
  • Hepatitis
  • Clinical Trial
  • Industry analysis
  • Infectious Disease Prevalence

Market Spotlight: Obesity

  • $ 1318
  • February 2021
  • 52 pages

This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming and regulatory events, probability of ...

  • World
  • Asia
  • Obesity
  • Clinical Trial
  • Industry analysis
  • Drug Approval
About 96000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Infectious Disease Demographic Impact in Wales (UK) and England (UK)

  • October 2021
  • 19 pages
  • England
  • Wales
  • Pathology
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Cause-Specific Mortality Rate

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on